Rebalance’s iShares iBonds Dec 2029 Term Corporate ETF IBDU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6M Buy
458,533
+5,515
+1% +$128K 0.56% 19
2026
Q1
$10.5M Buy
453,018
+17,621
+4% +$412K 0.61% 18
2025
Q4
$10.2M Buy
435,397
+6,662
+2% +$156K 0.6% 17
2025
Q3
$10.1M Buy
428,735
+244,087
+132% +$5.7M 0.61% 17
2025
Q2
$4.31M Buy
184,648
+1,765
+1% +$40.7K 0.29% 27
2025
Q1
$4.23M Buy
182,883
+31,503
+21% +$722K 0.31% 27
2024
Q4
$3.45M Buy
+151,380
New +$3.49M 0.26% 31

Other funds holding IBDU

Rebalance's IBDU Position: Q2 2026 in Review

Rebalance increased its iShares iBonds Dec 2029 Term Corporate ETF (IBDU) stake by 1.2% in Q2 2026, buying an estimated $128K and bringing the position to 458,533 shares worth $10.6M. The position accounts for 0.56% of the portfolio, ranked #19.

Rebalance first reported a position in IBDU in Q4 2024 and has held it in 7 quarters since. 386 funds tracked by Wall St. Rank hold IBDU as of Q2 2026.

  • Rebalance held 458,533 shares of iShares iBonds Dec 2029 Term Corporate ETF worth $10.6M as of Q2 2026.
  • Rebalance bought 5,515 iShares iBonds Dec 2029 Term Corporate ETF shares in Q2 2026, an estimated $128K.
  • iShares iBonds Dec 2029 Term Corporate ETF made up 0.56% of Rebalance's portfolio in Q2 2026, its #19 holding.
  • Rebalance first reported a position in iShares iBonds Dec 2029 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • 386 funds tracked by Wall St. Rank held iShares iBonds Dec 2029 Term Corporate ETF as of Q2 2026.

Based on Rebalance's 13F filing for Q2 2026, filed 16 Jul 2026.